The inability to grow human noroviruses in cell culture has greatly impeded the studies of their pathogenesis and immunity. Vesiviruses, in the family Caliciviridae, grow efficiently in cell culture and encode a unique protein in the subgenomic region designated as leader of the capsid protein (LC). We hypothesized that LC might be associated with the efficient replication of vesiviruses in cell culture and promote the replication of human norovirus in cells. To test this hypothesis, a recombinant plasmid was engineered in which the LC region of feline calicivirus (FCV) was placed under the control of the cytomegalovirus promoter (pCI-LC) so that the LC protein could be provided in trans to replicating calicivirus genomes bearing a reporter gene. We constructed pNV-GFP, a recombinant plasmid containing a full-length NV genome with a green fluorescent protein (GFP) in the place of VP1. The transfection of pNV-GFP in MVA-T7-infected cells produced few GFP-positive cells detected by fluorescence microscopy and flow cytometry analysis. When pNV-GFP was cotransfected with pCI-LC in MVA-T7-infected cells, we observed an increase in the number of GFP-positive cells (ca. 3% of the whole-cell population). Using this cotransfection method with mutagenesis study, we identified potential cis-acting elements at the start of subgenomic RNA and the 3 end of NV genome for the virus replication. We conclude that LC may be a viral factor which promotes the replication of NV in cells, which could provide a clue to growing the fastidious human noroviruses in cell culture.
Caliciviruses are plus-strand RNA viruses in the family Caliciviridae that consists of four genera: Norovirus, Sapovirus, Lagovirus, and Vesivirus. Viruses in the genera Norovirus and Sapovirus cause gastroenteritis in humans and animals. Recent studies estimate that noroviruses are responsible for more than 90% of nonbacterial gastroenteritis outbreaks (7) and as many as 23 million cases of gastroenteritis in the United States each year (21) . Norwalk virus (NV) is a prototype strain of the noroviruses and was associated with an outbreak of gastroenteritis in Norwalk, OH, in 1968 (16) . The viral genome of caliciviruses is 7 to 8 kb in length and organized into either two or three open reading frames (ORFs) that encode a polyprotein of approximately 1,800 amino acids (aa), the major capsid protein (VP1), and a minor capsid protein (VP2) (11, 14, 19, 33) . The first known calicivirus, vesicular exanthema swine virus (Vesivirus), was initially recognized in 1932. Vesicular exanthema swine virus may have arisen in swine from feed containing marine mammals infected with San Miguel sea lion virus, which causes vesicular lesions and reproductive failure in sea lions (23) . The genus Vesivirus includes feline caliciviruses (FCV), which is a major respiratory virus in cats and causes persistent respiratory infection (10) . The vesiviruses have been efficiently isolated in cell culture and provided a surrogate system for studying replication of the fastidious human enteric caliciviruses. Interestingly, vesiviruses encode a unique protein in the subgenomic region designated leader of the capsid protein (LC), and the expression of LC is a part of the LC-VP1 precursor that is processed to each mature protein by viral proteinase (Pro) (27) .
Although recent studies have presented evidence for the replication of human noroviruses in cells (1, 12, 29) , studies of the replication of these viruses have been severely hampered by the lack of a reliable cell culture system (6) . Among the noroviruses, only murine noroviruses (including MNV-1) (17) have been successfully propagated in cell culture (30) . Murine noroviruses are present widely in laboratory mouse colonies without apparent clinical symptoms (13, 31) . MNV-1 has a tissue tropism of macrophage-like cells in vivo and in vitro (30) , but it is not clear if human noroviruses target such cells. In the present study, we hypothesized that LC might be associated with the efficient replication of vesiviruses in cell culture and as a consequence may promote human norovirus replication in cells. We constructed a recombinant plasmid containing cDNA encoding the LC from FCV under the control of the cytomegalovirus (CMV) promoter (pCI-LC) to test this hypothesis. Previously, we reported an NV replicon system (NV replicon-bearing cells) using a recombinant plasmid containing a full-length NV genome (pNV101) (8) with a neomycin resistance gene (Neo r ) in the place of VP1 (pNV-Neo) (3, 5) . Using a similar strategy, we constructed pNV-GFP, where Neo r was replaced by a gene encoding green fluorescent protein (GFP). We also constructed a similar plasmid with GFP inserted into the ORF2 of the infectious clone of FCV (pQ14), pQ-GFP, for comparative studies. Cotransfection studies with pNV101, pNV-GFP, pQ14, or pQ-GFP with pCI-LC showed that LC promoted the replication of both FCV and NV in cells. Furthermore, we found that this cotransfection method was useful in the identification of cis-acting elements for NV replication in cells, which provides a novel tool for studying RNA elements. Using this system, we identified RNA elements at the start of the subgenomic RNA and 3Ј end of NV genome essential for virus replication.
MATERIALS AND METHODS
Cells and reagents. BHK21, HEK293T, and Vero cells were maintained in Dulbecco minimal essential medium containing 10% fetal bovine serum and antibiotics (chlortetracycline [25 g/ml] , penicillin [250 U/ml], and streptomycin [250 g/ml]). Crandell-Ress feline kidney (CRFK) cells were maintained in minimal essential medium containing 5% fetal bovine serum and antibiotics. Polyclonal antibodies to NV VP1 or FCV VP1 have been described previously (24) . We also used a polyclonal antibody to FCV LC that was described previously (25) . Monoclonal antibodies to NV VP1 were purchased from Chemicon (Temecula, CA).
Plasmid construction and generation of region-specific antisera. Standard recombinant DNA methods were used for the construction of plasmids. The consensus full-length clone of NV, pNV101, has been described previously (8) . We reported pNV-Neo, which is used for generating NV replicon-bearing cells based in BHK21 or Huh-7 cells (5). We generated a similar reporter plasmid based on NV101 with a gene encoding GFP, pNV-GFP, to study the replication of NV (Fig. 1) . For the construction of pNV-GFP, the GFP gene was amplified from the pAcGFP1 vector (Clontech, Mountain View, CA) with the primers GFP-NV-F (aattggatccTA TGGTG AGCAAGGGCGAGGA) and GFP-NV-R (aattaccggtTCAAGCTCGAG ATCTGAGTC) (the italic bases in the primers indicate the start and stop codons of GFP). The PCR product was digested with BamHI and AgeI (the sites underlined in the primers) and cloned into the corresponding sites of pNV-Neo. The resulting construct contained the GFP gene engineered into the 5Ј-end region of the ORF2 so that the expressed product would contain the first 33 aa of the VP1 fused in frame with GFP (Fig. 1B) . Similarly, we constructed pNV-RL (for Renilla luciferase) after the Renilla luciferase was amplified with primers NV-Bam-Luc-F (ataaggatccTATG GAAGACGCCAAAAAC) and NV-Age-Luc-R (aattaccggtTTACAATTTG GACTTTCCG), using pRL-CMV (Promega, Madison, WI) as a template. The viral polymerase (Pol) active site, GDD in pNV101, pNV-GFP, or pNV-RL, was deleted by using a site-directed mutagenesis kit (Stratagene, La Jolla, CA) and the primers N-⌬GDD-F (CATGTCATATTTCTCATTTTATGAGATTGTGTCAACTGACA TAG) and N-⌬GDD-R (CTATGTCAGTTGACACAATCTCATAAAATGAGA AATATGACATG), generating the pNV101⌬GDD, pNV-GFP⌬GDD, or pNV-RL⌬GDD plasmids, respectively (underlined bases indicate the position of the deletion of nine bases encoding GDD between them). To examine transfection efficiency, we generated a plasmid expressing chimeric VP1(33aa)-GFP fused to the end of NV ORF1 by deleting a base (G) at position 5354 in pNV-GFP by mutagenesis. The primers used for this deletion were M5354DG-F (CTTCTGCCCGAATT CTAAATGAT GATGGCG) and M5354DG-R (CGCCATCATCATTTAGAAT TCGGGCAGAAG) (underlined bases indicate the position of the deletion of G between them). Transfection of this plasmid yields expression of GFP, as a part of viral Pol-VP1(33aa)-GFP (unpublished observation). This plasmid was used to measure the transfection efficiency for the expression of NV ORF1 in MVA-T7-infected cells. We also generated pCI-GFP, which produces the expression of GFP under the CMV promoter control to measure overall transfection efficiency. The GFP gene was amplified by PCR using pAcGFP1 as a template with the primers GFP-Xho-F (aattctcgagATGGTGAGCAAGGGCGAGGA) and GFP-Not-R (aattgcggccgcTC AAGCTCGAGATCTGAGTC). The amplicon was cloned into pCI vector using the enzyme sites for XhoI and NotI.
For comparative studies, we also generated pQ-GFP based on the infectious clone of FCV Urbana strain, pQ14 (24) . We utilized the enzyme sites of SanDI and SpeI in the ORF2 of FCV to insert GFP. Briefly, the GFP gene was amplified from the pAcGFP1 vector (Clontech) with the primers GFP-FCV-F (aattgggacccCATGGT GAGCAAGGGCGAGGA) and GFP-FCV-R (aattactagtTCAAGCTCGAGAT CTGAGTC). The PCR product was digested with SanDI and SpeI and cloned into the corresponding sites of the pQ14 plasmid. Also, the viral Pol active-site GDD in pQ14 or pQ-GFP was deleted by using the site-directed mutagenesis kit with the primers FCV-⌬GDD-F (CGACATGATGACTTATGGTGTTTACATGTTTC) and FCV-⌬GDD-R (GAAACATGTAAACACCATAAGTCATCATGTCG), generating pQ14⌬GDD and pQ-GFP⌬GDD, respectively.
To examine the effects of LC from FCV on the replication of FCV or NV, we generated a plasmid containing the LC gene under the control of CMV promoter (pCI-LC). For the pCI-LC, the region encoding LC in FCV was amplified with the primers FCVLC-Xho-F (aattctcgagATGTGCTCAACCTGCGCTAACG) , and pQ-GFP. pNV-GFP was generated using unique sites of BamHI and AgeI in ORF2 of the NV genome, and GFP gene was cloned in place of VP1. pQ-GFP was generated using the unique restriction sites SanDI and SpeI in ORF2 of the FCV genome, and the GFP gene was cloned in the place of LC and VP1.
VOL. 82, 2008 LC IN FCV PROMOTES REPLICATION OF NV 9307
and FCVLC-Not-R (aattgcggccgcTTATCATTCCAATCTGAACAATGGCA) by PCR, using pQ14 as a template. The amplicon was cloned into pCI vector using the enzyme sites of XhoI and NotI. Similarly, we generated a plasmid containing the V gene of simian virus 5 (SV5) under the control of the CMV promoter (pCI-V). The gene encoding the V protein in SV5 (DA strain) was amplified with the primers SV5V-Nhe-F (aattgctagcATGGATCCCACTGATC TGAGC) and SV5V-Not-R (aattgcggccgcTTAAGTATCTCGTTCACATT CAG) by reverse transcription-PCR (RT-PCR), using viral RNA as a template. The RT-PCR was performed using the following conditions: 45°C for 30 min (for RT) and 95°C for 10 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 50°C for 1 min, and elongation at 72°C for 1 min. The amplicon was cloned into pCI vector using the enzyme sites of NheI and NotI. Also, we generated a plasmid, pNVP1 to express NV VP1 in cells for a control. The region encoding NV VP1 was amplified by PCR with the primers NVP1-Xho-F (aattc tcgagATGATGATGGCGTCTAAGG) and NVP1-Not-R (aattgcggccgcTTATC GGCGCA GACCAAGC) (the italic bases in the primers indicate the start and stop codons of VP1) using pNV101 as a template. The amplicon was cloned into pCI vector using the enzyme sites XhoI and NotI. Transfection study. All transfections were performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) with 2 g of each plasmid per well in six-well plates (ca. 1 ϫ 10 6 to 2 ϫ 10 6 cells). Cells including BHK21, HEK293T, or Vero cells were infected with the modified vaccinia virus (Ankara strain) expressing T7 Pol (MVA-T7) (32) at a multiplicity of infection of 10 for 1 h before transfection. The plasmid pNV101, pNV-GFP, pQ14, pQ-GFP, pNV101⌬GDD, pNV-GFP⌬GDD, pQ14⌬GDD, or pQ-GFP⌬GDD was transfected alone or cotransfected with pCI-LC or pCI-V to study the effects of LC or V in the replication of FCV or NV. The plasmid NV-GFP or pNV-GFP⌬GDD was also cotransfected with pCI-LC and pCI-V to study the combined effects of LC and V on NV replication. Similarly, each mutant plasmid of pNV-GFP (described below) was cotransfected with pCI-LC and pCI-V into MVA-T7-infected Vero cells to study cis-acting elements of NV. After transfection, the replication of FCV or NV was monitored by detecting the expression of VP1 or GFP (GFP-based constructs) with the various assays described below. In addition, plasmid pNV-RL or plasmid pNV-RL⌬GDD was transfected alone or with pCI-LC, pCI-V, or pCI-LC plus pCI-V into MVA-T7-infected Vero cells. For the control of this transfection, we used pCI and pNV-GFP. At 20 h posttransfection, cell lysates were prepared for Renilla luciferase activity using the Renilla luciferase assay system (Promega).
Virus replication assay. Virus replication was measured by various assays including immunofluorescence assay (IFA), Western blot analysis, enzymelinked immunosorbent assay (ELISA), plaque-forming assay (for FCV), and flow cytometry analysis.
(i) Detection of NV or FCV VP1. The expression of NV or FCV VP1 was measured by IFA using antibody against NV virus-like particles (VLPs) or FCV virions. Cells transfected with various plasmids were fixed with cold methanol at 18 to 24 h posttransfection for IFA. Monoclonal antibody to NV VLPs or polyclonal antibody (guinea pig serum) to FCV virions were added to the fixed monolayers, and the binding of antibodies was detected with fluorescein isothiocyanate-conjugated, affinity-purified goat antibodies to mouse or guinea pig immunoglobulin G (Sigma-Aldridge, St. Louis, MO) as described previously (4). NV VP1 was also detected by Western blot analysis using polyclonal antibody to the protein as described previously (5) . We also used ELISA for detecting NV VP1 after the transfections. Briefly, 96-well plates (Nunc, Rochester, NY) were coated with monoclonal antibody to NV VP1 as a capture antibody. Reagents were added to triplicate wells in the following sequence: cell lysate samples; hyperimmune guinea pig antiserum specific for NV VP1; goat anti-guinea pig immunoglobulin G conjugated to horseradish peroxidase; and the substrate tetramethylbenzidine (Kirkegaard & Perry Laboratories, Gaithersburg, MD). The absorbance was measured at 610 nm. The cutoff value was calculated as an absorbance at 610 nm that was at three standard deviations above the absorbance in cell control wells (cells infected with MVA-T7).
(ii) Detection of NV genome. To examine NV genome levels in the cells with various transfections, real-time quantitative RT-PCR (qRT-PCR) was performed by using a One-Step Platinum qRT-PCR kit (Invitrogen) according to the protocol established for the analysis of genogroup 1 norovirus samples (15) . The primers COG1F (CGYTGGATGCGNTTYCATGA) and COG1R (CTTA GACGCCATCATCATTYAC) and the probe RING1(a)-TP (FAM-AGATYG CGATCYCCTGTCCA-TAMRA) were used for the real-time qRT-PCR, which targets genomic RNA (sequence between positions 5291 and 5375) (15) . As a quantity control of cellular RNA levels, qRT-PCR for ␤-actin with the primers actin-F (GGCATCCACGAAACTACCTT) and actin-R (AGCACTGTGTTGG CGTACAG) and the probe actin-P (HEX-ATCATGAAGTGTGACGTGGAC ATCCG-TAMRA) was performed as described previously (3, 28) . For qRT-PCR, the total RNA of cells (in six-well plates) was extracted with an RNeasy kit (Qiagen, Valencia, CA). The qRT-PCR amplification was performed in a Cepheid SmartCycler with the following parameters: 45°C for 30 min and 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 50°C for 1 min, and elongation at 72°C for 30 s. The relative genome levels in cells with various transfection were calculated after the RNA levels were normalized with those of ␤-actin.
(iii) Expression of GFP. After the transfection of plasmids encoding the GFP gene, GFP-positive cells were detected by fluorescence microscopy or enumerated by using flow cytometry analysis. After 16 to 20 h of transfection, the cells were treated with trypsin, fixed with 4% formaldehyde for 1 h, and then washed twice with phosphate-buffered saline by centrifugation and resuspended with phosphate-buffered saline. Flow cytometry analysis was performed on a population of 10,000 cells by using a FACSCalibur (BD Biosciences, Franklin Lakes, NJ). M5354RC-F  G5354C  CTTCTGCCCGAATTCCTAAATGATGATGGCG  M5354RA-F  G5354A  CTTCTGCCCGAATTCATAAATGATGATGGCG  M5354RT-F  G5354U  CTTCTGCCCGAATTCTTAAATGATGATGGCG  M5355RA-F  U5355A  CTTCTGCCCGAATTCGAAAATGATGATGGCG  M5355RC-F  U5355C  CTTCTGCCCGAATTCGCAAATGATGATGGCG  M5355RG-F  U5355G  CTTCTGCCCGAATTCGGAAATGATGATGGCG  M5356RT-F  A5356U  CTTCTGCCCGAATTCGTTAATGATGATGGCGTC  M5356RC-F  A5356C  CTTCTGCCCGAATTCGTCAATGATGATGGCGTC  M5356RG-F  A5356G  CTTCTGCCCGAATTCGTGAATGATGATGGCGTC  M5357RT-F  A5357U  TTCTGCCCGAATTCGTATATGATGATGGCGTCTA  M5357RC-F  A5357C  TTCTGCCCGAATTCGTACATGATGATGGCGTCTA Mutagenesis of potential cis-acting elements in pNV-GFP. The potential promoter or cis-acting elements located at the start of subgenomic RNA or the 3Ј end in NV genome was examined by substitution and deletion mutagenesis of pNV-GFP (see Fig. 6A and 7) . First, we generated a series of substitute mutants at the start of the subgenomic RNA focusing on four untranslated bases, GUAA, using the primers listed in Table 1 . The substitution mutants at the first base (G) in the subgenomic RNA to U, A, or C were designated as pNV-GFP- . These mutations changed the asparagine to tyrosine, histidine, or aspartic acid, respectively. Second, to examine the RNA elements at the 3Ј end of NV genome for virus replication, we generated a series of deletion mutations targeting the regions between the stop codon of GFP and the end of genome (Fig. 7) . Nine deletion mutants were generated between the bases after the GFP gene, and the deletions corresponded to bases 7080, 7089, 7480, 7500, 7534, 7600, 7610, 7630, and 7640 (Fig. 7) . These mutations were generated by inserting an AgeI site at the desired bases using the mutagenesis kit and primers listed in Table  1 . The plasmids containing the mutants were digested with AgeI, which removed the deletion fragments and then they were religated to generate each mutant plasmid. The presence of the mutation for all plasmids described above was confirmed by sequencing analysis.
Statistical analysis. All experiments, including flow cytometry, Renilla luciferase assay, IFA, and ELISA, were conducted with at least three independent measurements, and the effects of LC protein, V protein, and the combination of LC protein plus V protein on FCV or NV replication were analyzed by using the Student t test. The results were considered statistically significant when the P value was Ͻ0.05. with MVA-T7 infection showed that more than 50% of the cells were positive with LC as detected by IFA. Also, the transfection of pCI-GFP showed similar rates of cells expressing GFP in each cell type. We first examined the effects of LC in FCV replication using pQ14 and pQ-GFP, which served as the framework of the system for studying the replication of NV. The transfection of pQ14 or pQ-GFP into MVA-T7-infected BHK21, HEK293T, and Vero cells resulted in the cells expressing VP1 or GFP, respectively. When we enumerated cells expressing GFP after the transfection of pQ-GFP in Vero cells, Ͻ4% of the whole population were GFP positive ( Fig. 2A) . The overall proportions of cells expressing GFP or VP1 (detected by IFA) after transfection of pQ14 or pQ-GFP were similar (Fig. 2B ). Cells transfected with pQ14 produced viable FCV, which indicated complete replication in these cell lines (Fig. 2) . For example, the titers of viral progeny after transfections of pQ14 in Vero cells were between 10 3 and 10 4 PFU/ml (Fig. 2C) . The transfection of RNA transcripts derived from pQ14 or pQ-GFP showed lower percentages (Ͻ1%) of cells expressing VP1 or GFP, respectively (unpublished observations). When pQ14 or pQ-GFP was cotransfected with pCI-LC in Vero cells after MVA-T7 infection, the cells expressing VP1 or GFP increased to ϳ2-fold over those with pQ14 or pQ-GFP transfection alone ( Fig. 2A and B) . The number of GFP expressing cells by the cotransfection with pCI-LC and pQ-GFP was significantly higher (P Ͻ 0.05) than the transfection with pQ-GFP alone. Although the cotransfection increased the number of GFP-positive cells, the overall intensity of GFP expression in each cell was reduced by the cotransfection. In Fig. 2A , the distribution of GFP-expressing cells leaned toward to the cutoff line by the cotransfection with pQ-GFP and pCI-LC (middle panel) compared to the transfection with pQ-GFP alone (upper panel). The virus titers after the transfection of pQ14 with or without pCI-LC in Vero cells were similar to each other, yielding approximately 2 ϫ 10 3 PFU/ml (Fig. 3C ). Transfection of pQ14⌬GDD or pQ-GFP⌬GDD with or without pCI-LC did not produce VP1-or GFP-positive cells above the level of the control MVA-T7-infected cells ( Fig. 2A and B) .
RESULTS

The
In the presence of LC, the replication of NV was promoted in cells. The transfection of pNV-GFP in BHK21, HEK293T, or Vero cells did not produce GFP-positive cells above the level of control MVA-T7-infected cells as measured by flow cytometry analysis (Fig. 3B) , although under a fluorescence microscope, few GFP-positive cells (fewer than five cells) were observed in one well of a six-well plate. The transfection of pNV-ORF1-GFP, which served as a control for transfection efficiency in Vero cells infected with MVA-T7, produced ca. 20% GFP-positive cells by flow cytometry analysis (Fig. 3A and  B) . When pNV-GFP was cotransfected with pCI-LC into MVA-T7-infected Vero cells, we found that ca. 3% cells expressed GFP as detected by flow cytometry analysis (Fig. 3A  and B) . Cotransfection of the same plasmids in BHK21 or HEK293T cells also produced GFP-positive cells, but with a rate of ca. 1%. The transfection of pNV-GFP⌬GDD with or without pCI-LC into MVA-T7-infected Vero, BHK21, and HEK293T cells did not yield GFP-positive cells by fluorescence microscopy or flow cytometry analysis (Fig. 3A and B) . The transfection study with pNV-RL or pNV-RL⌬GDD was consistent with the results of pNV-GFP or pNV-RL⌬GDD, showing that while transfection of pNV-RL alone induced a slight increase in Renilla luciferase expression, the cotransfection with pCI-LC significantly increased (P Ͻ 0.01) the expression levels of Renilla luciferase ( Table 2) . 
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We next examined cotransfection of pNV101 and pCI-LC into Vero cells to evaluate the effect of LC on NV replication. The transfection of pNV101 alone into MVA-T7-infected cells showed no evidence of VP1 expression (by IFA, Western blot analysis, or ELISA; Fig. 4 ). However, when pNV101 was cotransfected with pCI-LC into MVA-T7-infected cells, we could observe cells expressing VP1 by IFA (Fig. 4A) and Western blot analysis (Fig. 4B) and ELISA (Fig. 4C) . When the Pol motif GDD was deleted in pNV101 (pNV101⌬GDD), the transfection of this mutant plasmid with or without pCI-LC in cells did not produce any expression of VP1 (Fig. 4) . The NV RNA levels after the transfection measured by real-time qRT-PCR showed that cotransfection of pNV101 or pNV-GFP with pCI-LC increased the RNA levels ϳ2-fold (P Ͻ 0.05) over those of cells transfected with pNV101 or pNV-GFP alone (Table 3) .
The expression of LC and V synergistically increased NV replication. The V protein of SV5 downregulates the interferon (IFN) system by degrading STAT1 and enhances the replication of various viruses in vitro (34) . First, we confirmed the expression of V protein after transfection of pCI-V in various cells (BHK21, HEK293T, and Vero cells) using a firefly luciferase reporter plasmid under the control of the IFN stimulating response element (pISRE-luc) (unpublished observations) as described previously (5) . The cotransfection of pNV-GFP and pCI-V into MVA-T7-infected Vero cells also produced GFP-positive cells but with much less efficiency than pCI-LC (ca. 1% of total cells; Fig. 5 ). Interestingly, there were synergistic effects of LC and V in promoting NV replication. Cotransfection of pNV-GFP, pCI-LC, and pCI-V yielded ca. 5.5% of GFP-positive cells in Vero cells (Fig. 5) . The cotransfection study with pNV-RL, pCI-LC, and pCI-V confirmed the synergistic effects of LC and V protein, since cotransfection significantly increased Renilla luciferase expression levels by cotransfection over that of LC or V protein alone (Table 2) .
Mutagenesis studies. We applied the cotransfection method with three plasmids-pNV-GFP, pCI-LC, and pCI-V-to the identification of a potential cis-acting element in the start of subgenomic region and 3Ј end of the NV genome. Each pNV-GFP-based mutant plasmid was cotransfected with pCI-LC plus pCI-V, and GFP expression was observed under a fluorescence microscope and enumerated with flow cytometry .......................................................................................  NA  pNV-GFP ..............................................................................  1  pNV-GFP⌬GDD.................................................................. 0.92 Ϯ 0.3  pNV-GFP/pCI-LC................................................................ 2.1 Ϯ 0.3*  pNV-GFP⌬GDD/pCI-LC .............................................. analysis. Table 4 and Fig. 6 to 8 summarize the results of the cotransfection study. First, the noncoding bases (GUAA) at the start of subgenomic RNA were examined for their role in virus replication by mutagenesis study. The first base at the beginning of subgenomic RNA, G, was essential for the replication of NV in this system. When the first base, G, was mutated to U, A, or C (pNV-GFP-G 5354 U , pNV-GFP-G 5354 A , or pNV-GFP-G 5354 C ), cotransfection of each plasmid with pCI-LC and pCI-V yielded few GFP-positive cells ranging from ca. 0.02 to 0.03% (Fig. 6B and Table 4 ). For the second base, U, while its mutation to A or C abolished the replication of NV in the system (0.02 to 0.03%), its mutation to G resulted in comparable numbers of GFP-positive cells (5.1%) to that of the parental pNV-GFP (Fig. 6C, Table 4 , and Fig. 5 ). The third (A) or fourth base (A) did not appear to be essential for virus replication. The mutation of the third or fourth base to any bases yielded similar (or slightly lower, but without statistical significance) numbers of GFP-positive cells ranging from 4.1 to 4.5% to that of the parental pNV-GFP after cotransfection in Vero cells (Table 4) .
We also examined the 3Ј end of the NV genome for potential cis-acting elements by generating a series of deletion mutants of pNV-GFP. The designation of each plasmid-pNV-GFP (Table 4 and Fig. 7 and 8 ), These results indicated that the 3Ј untranslated region (3ЈUTR) and the last part of the RNA sequences encoding ORF3 was essential, containing cis-acting elements for virus replication.
DISCUSSION
The inability to grow human noroviruses in cell culture greatly impedes studies of their pathogenesis and immunity. In this report, we report NV replicon plasmids with reporter genes, pNV-GFP or pNV-RL, for studying the replication of NV in cells. During the generation of NV replicon-bearing cells with pNV-Neo in our previous study, we noticed that only a few populations of cells (either BHK21 or Huh-7) could support NV replication when selected by the antibiotics. The initial study of transfecting pNV-GFP alone was consistent with the observation that only few of the transfected cells expressed GFP. The enumeration of GFP-positive cells by flow cytometry failed to yield significant numbers above the level of control cells. However, we were consistently able to observe some GFP-positive cells under a fluorescence microscope after the transfection of pNV-GFP regardless of cell types. In the case of hepatitis C virus (HCV), a phenomenon similar to that seen for NV was observed during the generation of repliconbearing cells: only a few cells in the population of Huh-7 were susceptible to replication of HCV (20) . Viral and cellular factors that promote the replication of HCV in cell culture have been identified. As viral factors, adaptive mutations in the HCV genome led to the susceptible population and efficiency of selecting replicon-harboring cells increased up to 1,000-fold in Huh-7 cells (2, 18) . Cellular factors have also been identified for HCV replication: cells with mutations in the IFN system (the retinoid-inducible gene 1) were much more susceptible to HCV replication than the parental cells (2, 9). However, unlike HCV, we could not identify such adaptive mutations in the viral genome for NV replication in a similar study with NV replicon-bearing cells (5) . To identify any viral factors which may promote the replication of NV, our attention was focused on the observation that vesiviruses grow efficiently in cell culture and encode a unique protein in the subgenomic region designated LC. Our hypothesis was that LC might be associated with the efficient replication of vesiviruses in cell culture and, if so, it might promote human norovirus replication in cells. When we enumerated cells expressing GFP after the transfection of pQ-GFP alone in various cells, including Vero, BHK21, or 293T cells, with MVA-T7, Ͻ4% of the cell population was GFP positive, suggesting that even FCV has some restrictions on replication within the cells. This was consistent with the transfection of pQ14, where virus replication was measured by the IFA staining with VP1 antibody. However, cotransfection of pQ14 or pQ-GFP with pCI-LC indicated that LC increased the cell population susceptible to FCV replication by ϳ2-fold in these cell lines ( Fig. 2A and B) . Although the number of cells expressing GFP or VP1 increased by the cotransfection, virus titers after the transfection of pQ14 with or without pCI-LC were similar to each other (Fig. 2C) . One possible explanation is that the intensity of GFP and VP1 expression was reduced by the cotransfection with pCI-LC in the cells ( Fig. 2A and B) , which may offset the titers. The overexpression of LC triggers morphological changes (cell We also found that LC significantly reduced the expression of luciferase under the promoter of CMV after transfection (unpublished observation), suggesting that it might have an inhibitory effect on overall protein translation, probably due to the apoptosis. We are conducting further experiments to examine the role of LC in protein translation and apoptosis in correlation with the increased expression of FCV VP1 and GFP. When testing pCI-based plasmids containing LC from other FCV strains such as F9 (vaccine strain) or Ari (22) for the cotransfection study, we observed similar results, as they enhanced the expression of VP1 or GFP with FCV-based plasmids (unpublished observation). When we performed the same experiments with the reporter plasmids of NV, we found that LC promoted the replication of NV as well. First, the transfection of pNV101 or pNV-GFP into MVA-T7-infected cells (BHK21, HEK293T, or Vero cells) produced few VP1-or GFP-positive cells. However, cotransfection of pNV101 or pNV-GFP and pCI-LC produced significantly increased numbers of VP1-or GFP-positive cells, respectively, in those cells. The percentage of GFP-positive cells after the cotransfection of pNV-GFP and pCI-LC was ca. 3% of the whole population (Fig. 3) . Cotransfection of pNV-GFP and pCI-V also produced increased numbers of GFPexpressing cells, indicating the importance of innate immunity as a restriction factor for NV replication in cells. Furthermore, we found that there were synergistic effects of LC and V in promoting NV replication. We observed similar results with the full-length clone of NV, pNV101. Although transfection of pNV101 alone produced few VP1-positive cells, cotransfection of pNV101 and pCI-LC resulted in significant numbers of cells expressing VP1 as detected by various methods including IFA, 
